Showing results (221-230 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|September 21, 2016
Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatmentRoelof Aj Smit, Iris Postmus, Stella Trompet, et al.Pharmacogenomics|March 19, 2010
Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research NetworkElizabeth J Atkinson, Shannon K McDonnell, John S Witte, et al.Pharmacogenomics|March 19, 2010
Haplotypes of the adrenergic system predict the blood pressure response to beta-blockers in women with essential hypertensionFabiana Filigheddu, Giuseppe Argiolas, Simona Degortes, et al.Pharmacogenomics|March 19, 2010
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han ChineseShuen-Iu Hung, Wen-Hung Chung, Zhi-Sheng Liu, et al.Pharmacogenomics|August 23, 2016
Association between DCK 35708 T>C variation and clinical outcomes of acute myeloid leukemia in South Chinese patientsDao-Yu Zhang, Xiao-Qing Yuan, Han Yan, et al.Pharmacogenomics|July 8, 2017
Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirementAlison Lh Quinn, Ina Liko, James C LeePharmacogenomics|July 8, 2017
Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's diseaseSara Rufini, Cinzia Ciccacci, Giuseppe Novelli, et al.Pharmacogenomics|June 20, 2018
Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutationsZohra Chadli, Chayma Ladhari, Emna Kerkeni, et al.Pharmacogenomics|June 20, 2018
Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetesNagaraja M Phani, Manik Vohra, Ananth Kakar, et al.Pharmacogenomics|June 14, 2019
Big data in pharmacogenomics: current applications, perspectives and pitfallsClaire-Cécile Barrot, Jean-Baptiste Woillard, Nicolas PicardPageof 276